Non-contrast breast MRI for newly diagnosed breast cancer
Part of Cancer, Skin clinical trials.
This study tests a new, shorter breast MRI that does not require a contrast dye to see if it works as well as the standard MRI for evaluating newly diagnosed breast cancer. It could mean fewer side effects and a quicker scan for patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older.
- You have been diagnosed with breast cancer and it is your first diagnosis.
- You are already scheduled for a contrast-enhanced breast MRI at Massachusetts General Hospital.
- You are not pregnant and have no medical devices or metal in your body that would make an MRI unsafe.
- You can lie still for the MRI and complete an extra 5-minute scan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special type of mammogram, called contrast-enhanced mammography (CEM), can better spot additional breast abnormalities that were seen on your MRI. It might help doctors decide on the best next steps without needing more invasive tests.
This study uses a breast MRI scan to look at suspicious areas in the breast. It may help doctors better tell which breast changes need closer follow-up like a biopsy.
This study uses breast MRI scans to see whether neoadjuvant (before-surgery) chemotherapy is working. If you qualify, you’ll have MRI scans to help doctors understand how your breast cancer responds to standard treatment.
This trial compares a special mammogram with dye (CEDM) to MRI for women already diagnosed with invasive breast cancer. The goal is to see if CEDM works as well as MRI for planning surgery, potentially offering a faster or easier option.
This study is testing whether adding an MRI to a normal mammogram can find more cancers in women with dense breasts. If you participate, you may benefit from extra monitoring and peace of mind.
This study compares two ways of imaging the breast—molecular breast imaging (a scan that uses a small radioactive tracer) and standard breast MRI—to better find or rule out breast cancer. You may join if you are considered high risk and already have a breast MRI planned, and you can do both tests close together.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.